These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9044819)

  • 21. Human hematopoietic stem cells: potential use as tumor-free autografts after high-dose myeloablative cancer therapy.
    Hoffman R
    Am J Med Sci; 1995 May; 309(5):254-9. PubMed ID: 7733140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood stem cells: promises and problems.
    Hardy C
    Blood Cells; 1991; 17(2):310-2. PubMed ID: 1680501
    [No Abstract]   [Full Text] [Related]  

  • 23. Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.
    Bertolini F; de Vincentiis A; Lanata L; Lemoli RM; Maccario R; Majolino I; Ponchio L; Rondelli D; Tabilio A; Zanon P; Tura S
    Haematologica; 1997; 82(2):220-38. PubMed ID: 9175330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New definition and methods for isolation of the earliest peripheral blood-derived hematopoietic stem cells.
    Huss R
    Beitr Infusionsther Transfusionsmed; 1997; 34():128-32. PubMed ID: 9356663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of hematopoietic stem cells in peripheral blood by an automated hematology analyzer (SE-9000).
    Takekawa K; Yamane T; Hino M; Tatsumi N
    Acta Haematol; 1998 Dec; 100(3):130-6. PubMed ID: 9858789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of human hematopoietic stem cells isolated and expanded from different tissues in regenerative medicine.
    Tripura C; Pande G
    Regen Med; 2013 Nov; 8(6):783-95. PubMed ID: 24147533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
    Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
    Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
    [No Abstract]   [Full Text] [Related]  

  • 28. The dielectrophoresis enrichment of CD34+ cells from peripheral blood stem cell harvests.
    Stephens M; Talary MS; Pethig R; Burnett AK; Mills KI
    Bone Marrow Transplant; 1996 Oct; 18(4):777-82. PubMed ID: 8899194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collection, processing, and banking of umbilical cord blood stem cells for transplantation and regenerative medicine.
    Badowski MS; Harris DT
    Methods Mol Biol; 2012; 879():279-90. PubMed ID: 22610565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization, quantitation and mobilization of early hematopoietic progenitors: implications for transplantation.
    Sutherland HJ; Hogge DE; Eaves CJ
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S1-4. PubMed ID: 8899157
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation.
    Civin CI
    Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
    Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
    Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.
    Pico JL; Bourhis JH; Bennaceur AL; Beaujean F; Bayle C; Ibrahim A; Girinski T; Hayat M; Dighiero G; Tchernia G
    Nouv Rev Fr Hematol (1978); 1995; 37(6):381-3. PubMed ID: 8907636
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality control for peripheral stem cell collection: the Ottawa experience.
    Giulivi A; Huebsch LB; Van der Jagt R; Markman S; Fuller V; Birch P; Demone J; McDiermid S; Rutherford B
    Prog Clin Biol Res; 1994; 389():753-9. PubMed ID: 7535465
    [No Abstract]   [Full Text] [Related]  

  • 36. CD34+ selected cells in clinical transplantation.
    Collins RH
    Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood stem cell collection after mobilization with intensive chemotherapy and growth factors.
    Dicke KA; Hood D; Hanks S
    J Hematother; 1994; 3(2):141-4. PubMed ID: 7522898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cells.
    Brugger W; Mertelsmann R; Kanz L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):221-3. PubMed ID: 7687768
    [No Abstract]   [Full Text] [Related]  

  • 39. Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.
    Villa NY; Bais S; Chan WM; Meacham AM; Wise E; Rahman MM; Moreb JS; Rosenau EH; Wingard JR; McFadden G; Cogle CR
    Cytotherapy; 2016 Mar; 18(3):465-80. PubMed ID: 26857235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harvesting autologous stem cells from a patient with red blood cell abnormalities of β-thalassemia intermedia.
    Sanford K; Roseff SD; Anderson J; Chung HM; McPherson RA
    Transfusion; 2014 Jul; 54(7):1881-6. PubMed ID: 24527966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.